Michael Houghton
Net worth: 88 567 $ as of 2026-05-30
Net worth: 88 567 $ as of 2026-05-30
Michael Houghton is Chairman-Virology and Professor at the University of Alberta since 2010.
Director at Li Ka Shing Institute of Virology.
Independent Director at Assembly Biosciences, Inc. since 2021.
Director at Achlys, Inc., Prophysis, Inc., Aurora Vaccines, Inc., Heka Therapeutics, Inc., and Egerio, Inc. Former Vice President-Hepatitis C & Virology Research at Novartis Vaccines & Diagnostics, Inc. Chief Scientific Officer at Epiphany Biosciences, Inc. from 2007 to 2009.
Former Professor at the University of Alberta.
Educated at the University of East Anglia (undergraduate) and King's College London (doctorate).
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-06-03 | 3,202 ( 0.02% ) | 88 567 $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| ASSEMBLY BIOSCIENCES, INC. | Director/Board Member | 2021-07-18 |
Li Ka Shing Institute of Virology
Li Ka Shing Institute of Virology Miscellaneous Commercial ServicesCommercial Services Engages in conducting research to develops hepatitis vaccines and antiviral therapies | Director/Board Member | - |
University of Alberta
University of Alberta Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 2009-12-31 |
Achlys, Inc. | Director/Board Member | - |
| Companies | Position | End |
|---|---|---|
Epiphany Biosciences, Inc.
Epiphany Biosciences, Inc. Medical SpecialtiesHealth Technology Develops therapeutic products and diagnostic technologies | Chief Tech/Sci/R&D Officer | 2008-12-31 |
University of Alberta
University of Alberta Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Novartis Vaccines & Diagnostics, Inc.
Novartis Vaccines & Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 8 |
|---|---|
Epiphany Biosciences, Inc.
Epiphany Biosciences, Inc. Medical SpecialtiesHealth Technology Develops therapeutic products and diagnostic technologies | Health Technology |
University of Alberta
University of Alberta Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of East Anglia
University of East Anglia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Vaccines & Diagnostics, Inc.
Novartis Vaccines & Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
King's College London
King's College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Li Ka Shing Institute of Virology
Li Ka Shing Institute of Virology Miscellaneous Commercial ServicesCommercial Services Engages in conducting research to develops hepatitis vaccines and antiviral therapies | Commercial Services |
Assembly Biosciences, Inc.
Assembly Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development of products for infectious diseases | Health Technology |
Achlys, Inc. |
Select your edition
All financial news and data tailored to specific country editions